Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of nonsteroidal anti-inflammatory drugs (NSAIDs) and other bioactive molecules. The presence of amino at position 2, bromo at 3, and trifluoromethyl at 5 on the benzoic acid scaffold allows for selective derivatization, making it valuable in constructing complex heterocyclic compounds. Commonly employed in medicinal chemistry as building blocks in drug discovery due to the amino and carboxylic acid functional groups, which facilitate coupling reactions. The trifluoromethyl group is also utilized in the preparation of fluorinated analogs to enhance metabolic stability and binding affinity in target compounds.